Ameriprise Financial Inc Nevro Corp Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Nevro Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 154,976 shares of NVRO stock, worth $643,150. This represents 0.0% of its overall portfolio holdings.

Number of Shares

154,976

Holding current value

$643,150

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.71 - $10.1 $729,936 - $1.57 Million	154,976 New	154,976 $864,000
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $19,198 - $26,033	527 Added 1.55%	34,481 $1.37 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $234,364 - $305,664	5,764 Added 20.45%	33,954 $1.58 Million
Q2 2022 Aug 15, 2022	BUY	$40.85 - $77.67 $73,039 - $138,873	1,788 Added 6.77%	28,190 $1.24 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $23,860 - $36,639	398 Added 1.53%	26,402 $1.91 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $46,534 - $69,620	574 Added 2.26%	26,004 $2 Million
Q3 2021 Nov 15, 2021	SELL	$101.99 - $166.36 $8 Million - $13.1 Million	-78,474 Reduced 75.53%	25,430 $2.96 Million
Q2 2021 Aug 16, 2021	BUY	$141.6 - $179.06 $2.36 Million - $2.98 Million	16,641 Added 19.07%	103,904 $17.2 Million
Q1 2021 May 17, 2021	BUY	$132.81 - $182.18 $1.64 Million - $2.25 Million	12,340 Added 16.47%	87,263 $12.2 Million
Q4 2020 Feb 12, 2021	BUY	$138.17 - $184.34 $1.77 Million - $2.36 Million	12,796 Added 20.6%	74,923 $13 Million
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $49,857 - $63,587	-437 Reduced 0.7%	62,127 $8.65 Million
Q2 2020 Aug 14, 2020	SELL	$89.45 - $129.85 $1.49 Million - $2.16 Million	-16,673 Reduced 21.04%	62,564 $7.46 Million
Q1 2020 May 15, 2020	BUY	$70.23 - $144.31 $398,485 - $818,814	5,674 Added 7.71%	79,237 $7.93 Million
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $366,233 - $563,369	-4,793 Reduced 6.12%	73,563 $8.65 Million
Q3 2019 Nov 14, 2019	BUY	$61.52 - $91.1 $933,196 - $1.38 Million	15,169 Added 24.01%	78,356 $6.74 Million
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $179,691 - $207,401	3,096 Added 5.15%	63,187 $4.09 Million
Q1 2019 May 15, 2019	BUY	$35.52 - $62.62 $637,619 - $1.12 Million	17,951 Added 42.6%	60,091 $3.76 Million
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $614,320 - $976,012	17,339 Added 69.91%	42,140 $1.64 Million
Q3 2018 Nov 14, 2018	SELL	$44.22 - $75.47 $1.83 Million - $3.13 Million	-41,470 Reduced 62.58%	24,801 $1.41 Million
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $1.26 Million - $1.61 Million	-17,384 Reduced 20.78%	66,271 $5.29 Million
Q1 2018 May 15, 2018	SELL	$69.46 - $88.57 $20.6 Million - $26.3 Million	-296,693 Reduced 78.01%	83,655 $7.25 Million
Q4 2017 Feb 12, 2018	BUY	$65.94 - $93.31 $13.3 Million - $18.8 Million	201,103 Added 112.19%	380,348 $26.3 Million
Q3 2017 Nov 07, 2017	BUY	$80.87 - $91.08 $14.5 Million - $16.3 Million	179,245	179,245 $16.3 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $147M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Nevro Corp Transaction History